Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• A ‘win’ for TAVR signals paradigm shift in treatment of aortic stenosis
• Gestational diabetes has long-term CV implications
• Age at type 2 diabetes diagnosis may impact survival, CVD outcomes
• Lifetime risk for hypertension exceeds 75% for black adults, white men
• Moderate alcohol intake increases BP, stroke risk in men
• Nearly 60% of eligible patients never offered statin therapy
• Prevalent CAC common in high-volume endurance activity athletes, but no long-term risk for mortality
• Stress-related disorders increase risk for CVD
• Antibacterial envelope reduces rate of cardiac device infections in WRAP-IT
• AUGUSTUS: Dual therapy with apixaban, P2Y12 inhibitor safe in Afib patients post-ACS or PCI
• Balloon-expandable TAVR safe in bicuspid aortic valves
• Bempedoic acid may further reduce LDL when added to high-intensity statin therapy
• COAPT: Transcatheter mitral valve replacement brings health status improvements
• Organizations must make meaningful system changes to battle physician burnout
• POET: Switch to oral antibiotics confers better outcomes in left-sided endocarditis
• Will an aspirin a day keep MI away? New evidence, recommendations from the ACC/AHA Ahmed Aldemerdash, BS, PharmD, BCPS; Leo F. Buckley III, PharmD, BCCP; Claudia Lopez, PharmD, BCPS; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
• BIOSOLVE-IV
• CLEAR Wisdom
• DIRECT
• EXPANDHeart
• MiCORE
• MRUSMI
• PARROT
• SAFARI-STEMI